Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/4/2025
Everest Acquires Exclusive Greater China and Other Asian Country Right...
11/4/2025
NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
11/4/2025
Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
11/4/2025
Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
11/4/2025
NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
11/4/2025
China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
10/31/2025
NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
10/31/2025
Asia Regenerative Medicine Completes Series A Funding
10/31/2025
Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
10/31/2025
Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
10/31/2025
Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
10/31/2025
Lumosa's Stroke Drug Achieves Phase IIb Success in China
10/31/2025
China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
10/31/2025
China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
10/29/2025
Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...
10/29/2025
NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...
10/29/2025
Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...
10/29/2025
Pharmaron to Acquire Biortus in China
10/29/2025
NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...
10/29/2025
China Issues Guidelines to Strengthen Primary Care Chronic Disease Man...
10/28/2025
Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...
10/28/2025
Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004
10/28/2025
Over 400 Companies Join China's 11th Round of VBP
10/27/2025
Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...
10/27/2025
Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...
10/27/2025
Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...
10/27/2025
AstraZeneca Unveils Three Major Initiatives in China
10/25/2025
Recent Executive Moves
10/24/2025
Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
10/24/2025
METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...
Page:
1
/
370
Total number of articles:
11093
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit